Pharmacogenomics in Cardiac Drugs

Dr. Peter O’Donnell, from the University of Chicago’s Committee on Clinical Pharmacology and Pharmacogenomics, and Dr. Matthew Sorrentino, a Professor of Medicine in the Section of Cardiology at the University of Chicago, in Illinois, dialogue on their article appearing in the June 2015 issue of Mayo Clinic Proceedings, where they completed a rigorous examination of cardiac drugs using genetic markers and provide clinicians with clinical endpoints for enhanced patient care. Available at: http://tinyurl.com/ogkav72